TRAVERE THERAPEUTICS (BILE ACID PRODUCT PORTFOLIO)
Summary
Travere’s bile acid product portfolio includes Cholbam® (cholic acid) and Chenodal® (chenodiol), two medications addressing rare diseases in high-need settings.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 367 M
Avg. Deal Size£ 367 M
© COPYRIGHT 2025 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.